• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Corporacion America Airports SA Common Shares
Dexterra Group Inc
Ishares Core MSCI All Cntry Ex Can ETF
Muenchener Re Gp ADR
Solstice Advanced Materials Inc. - Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Advanced Robotic Excision Surgery for Complex Endometriosis Cases Announced

By: Press Release Distribution Service
October 11, 2026 at 15:15 PM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Lotus Endometriosis Institute is announcing advanced robotic excision surgery for complex endometriosis, adapting the surgical approach to the complexity of each case and the outcomes that matter most to the patient.

Arroyo Grande, United States, October 11, 2026 -- Lotus Endometriosis Institute has announced robotic excision surgery for patients with complex endometriosis, including advanced and re-operative cases. Led by Dr. Steve Vasilev, the service adapts surgical planning to the location and extent of disease, previous treatment, fertility considerations, and each patient’s individual health goals.

More information is available at https://lotusendo.com/services/surgery-and-advanced-excision

The announcement comes as endometriosis continues to affect millions of women across the United States. According to a 2026 update published by StatPearls through the National Library of Medicine, approximately 9 million females in the U.S. have endometriosis, with cases ranging from relatively limited disease to complex involvement of multiple organs.

Endometriosis can affect different areas of the body, creating very different surgical challenges from one patient to another. Disease may involve the ovaries, fallopian tubes, bladder, bowel, appendix, diaphragm, pelvic nerves, and other structures, while previous operations can further alter anatomy.

Lotus uses robotic excision as its surgical approach, with three-dimensional visualization and articulated instruments supporting precise dissection in complex abdominal and pelvic anatomy. Depending on the individual case, planning may prioritize fertility and organ preservation or involve more extensive procedures when clinically appropriate.

Dr. Vasilev brings more than 30 years of surgical experience to this work. He is quadruple board-certified, fellowship-trained in gynecologic oncology, and experienced in minimally invasive robotic surgery involving complex pelvic anatomy.

“Endometriosis surgery has to be planned around the individual patient and the disease we are treating,” said Dr. Vasilev. “The location and extent of disease, previous procedures, fertility goals, and preservation of healthy function all influence how we approach excision.”

For patients with complex endometriosis, personalized surgical planning allows treatment decisions to account for more than the presence of disease alone. Considering reproductive goals, affected organs, previous treatment, and long-term function can help align surgery with what matters most to the individual patient.

Lotus Endometriosis Institute combines minimally invasive and robotic excision surgery with personalized recovery planning. Its care model considers nutrition, hormonal balance, stress modulation, and other factors that may influence long-term recovery.

More information about Lotus Endometriosis Institute and the available services can be found at https://lotusendo.com

Contact Info:
Name: Dr. Steven Vasilev
Email: Send Email
Organization: Lotus Endometriosis Institute
Address: 154 Traffic Way, Arroyo Grande, CA 93420, United States
Website: https://lotusendo.com

Source: PressCable

Release ID: 89205812

Should there be any problems, inaccuracies, or doubts arising from the content provided in this press release that require attention or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is central to our commitment.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More
News headline image
Maximus to Buy Agile Defense for $660M, Expanding AI and Cybersecurity Reach ↗
Today 3:02 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers MMS
News headline image
Spero Therapeutics Targets 2027 Phase II Launch for SP001 in IgG4-Related Disease ↗
Today 2:02 EDT
Via MarketBeat
Tickers SPRO
News headline image
Orion Energy Systems Expands Into EV Charging, Maintenance and Electrical Infrastructure ↗
Today 1:02 EDT
Via MarketBeat
Tickers OESX
News headline image
Zoom Communications Targets 6%-8% Growth by 2030 as AI Strategy Takes Center Stage ↗
Today 0:02 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers MSFT ZM
News headline image
Calix Conference Puts AI, Network Simplification at Center of Broadband Growth ↗
October 20, 2026
Via MarketBeat
Topics Artificial Intelligence
Tickers CALX

Recent Quotes

View More
Symbol Price Change (%)
AMZN  262.63
+0.18 (0.07%)
AAPL  339.50
-3.44 (-1.00%)
AMD  534.74
-3.31 (-0.62%)
BAC  50.64
+0.25 (0.50%)
GOOG  336.40
-3.76 (-1.11%)
META  694.25
-11.19 (-1.59%)
MSFT  531.87
-1.65 (-0.31%)
NVDA  216.47
-0.62 (-0.29%)
ORCL  131.14
+1.55 (1.20%)
TSLA  373.71
+5.65 (1.54%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap